Gene transfer to the respiratory tract by replication-deficient adenoviruses is limited by the induction of inflammatory and immune responses. We previously demonstrated that a E1-E3-deleted recombinant adenovirus carrying the expression cassette for the cystic fibrosis gene (Ad.CFTR) upregulates the expression of the pro-inflammatory intercellular adhesion molecule-1 (ICAM-1) both in vitro and in vivo. In the present work we suggest a role for the nuclear factor-kB (NF-kB) in Ad.CFTR-dependent up-regulation of ICAM-1 in respiratory epithelial A549 cells. Specifically, Ad.CFTR induced translocation of NF-kB into the nucleus and binding to the proximal −228/−218 NF-kB consensus sequence on the ICAM-1 pro-
Replication-deficient recombinant adenoviruses (Ad) have been applied in gene therapy studies directed against several genetic and acquired diseases, including cystic fibrosis (CF). Defective cystic fibrosis transmembrane conductance regulator (CFTR) causes impaired electrolyte transport in several epithelia, leading to functional insufficiency of different organs including the lung. Ad vectors carrying the expression cassette encoding the CF gene have been used in preclinical and clinical studies aimed to correct the CF respiratory pathology. A major limitation in the use of Ad-derived vectors in airway cells is the induction of inflammatory and immune responses, whose mechanisms are presently under investigation. First-generation recombinant Ad-derived vectors have been shown to up-regulate the expression of the proinflammatory intercellular adhesion molecule 1 (ICAM-1) both at transcript and protein levels in A549 cells in vitro. 1, 2 These findings have also been investigated in the lungs of nonhuman primates instilled with Ad.CFTR at different doses in vivo. Specifically, in the lung portions in which Ad.CFTR promoted an infiltrate of inflammatory cells, several fold elevation of ICAM-1 mRNA was found, confirming the association of ICAM-1 induction in Ad-dependent inflammatory response in vivo. 2 However, the molecular mechanism(s) of this induction has not been described yet. 
moter. Ad.CFTR also stimulated a 13-fold increase in NFkB-dependent expression of the CAT reporter gene under the control of a region of the ICAM-1 promoter, including the proximal NF-kB consensus sequence. The Ad.CFTR-dependent increase of ICAM-1 mRNA was abolished by inhibitors of NF-kB, such as N-acetyl-L-cysteine, pyrrolidine dithiocarbamate, parthenolide and the synthetic peptide SN50. All these inhibitors abolished both Ad.CFTR-induced NF-kB DNA binding and transactivating activities. These results indicate a critical role of NF-kB in the pro-inflammatory response elicited by replication-deficient adenoviral vectors in respiratory cells. Gene Therapy (2001) 8, 1436-1442.
Pro-inflammatory cytokines and other agents are able to regulate ICAM-1 gene transcription by distinct pathways leading to the activation of multiple transcription factors. 3 Among binding sites for several nuclear factors, consensus sequences for the NF-kB have been described in the ICAM-1 5′ flanking region. 4 Lipopolysaccharide, respiratory syncytial virus and rhinovirus are known to increase NF-kB-mediated transcription of the ICAM-1 gene in A549 cells. [5] [6] [7] Recombinant adenoviral vectors have been shown to activate NF-kB in murine hepatocytes, murine dendritic cells and human vascular smooth muscle cells. [8] [9] [10] These reports suggested a role for NFkB in the transcriptional regulation of ICAM-1 gene induced by Ad.CFTR. Inactive NF-kB/Rel proteins are located in the cytoplasm as heterodimers and homodimers which are bound to inhibitory proteins termed IkBs. The most common form of NF-kB in mammals is a dimer composed of subunits termed p50 and p65 (RelA). Many different stimuli including bacteria, viruses and cytokines promote degradation of Ik-Bs allowing NF-kB translocation from the cytoplasm to the nucleus, where NF-kB binds to a set of related DNA target sequences, called kB sites. 11 Following the first description in B cells, NF-kB was quickly demonstrated to be a member of a ubiquitously expressed family of Rel-related transcription factors capable of regulating the transcription of a large variety of genes involved in apoptosis, cell growth, response to inflammatory and stress signals, limb development, bone remodeling and immune response. [12] [13] [14] We tested the effect of four inhibitors affecting the steps of the NF-kB activation cascade at the levels described schematically in Figure 1 . The antioxidants Nacetyl-L-cysteine (NAC) and pyrrolidine dithiocarbamate (PTDC) prevent the increase of reactive oxygen intermediates capable of stimulating Ik-Bs degradation. 15, 16 Ik-B bound to NF-kB in the cytoplasm masks the nuclear localization sequences of the NF-kB dimer and therefore blocks nuclear translocation of this transcription factor. Parthenolide causes cytoplasmic retention of inactive NFkB by inhibiting phosphorylation and/or degradation of Ik-B. 13, 17, 18 The synthetic peptide SN50, containing a cell membrane-permeable motif and an NF-kB nuclear localization sequence (NLS), prevents subcellular traffic of NF-kB complexes from the cytoplasm to the nucleus; it competes for the cellular machinery responsible for nuclear translocation of NF-kB. The peptide SN50M has mutations in two of the 10 residues within the NLS of SN50 and is used as control for specificity of inhibition by SN50. 19 The effect of these inhibitors was first tested on ICAM-1 mRNA expression, which was quantitated by single-tube competitive RT-PCR as described. 2 We utilized the model system of the alveolar type II-derived A549 cells exposed to Ad.CFTR for 24 h. Figure 2a shows that Ad.CFTR up-regulated ICAM-1 mRNA levels from two-to four-fold at doses ranging from 0.1 to 50 MOI. NF-kB inhibitors were added to cells 1 h before exposure to Ad.CFTR at MOI 10. Figure 2b shows that pre-incubation of cells with PDTC, NAC, SN50 and parthenolide maintained ICAM-1 transcripts within or below the level measured in cells not exposed to the vector. Mutated peptide SN50M did not affect Ad.CFTR-induced ICAM-1 
not shown). The finding that PDTC, NAC, SN50 and parthenolide do not inhibit Ad.CFTR infection was tested as previously described by analysis of expression of the vector-encoded CFTR transcripts (not shown).
mRNA expression, confirming the specificity of the effect of SN50. The full inhibitory effect observed with PDTC, NAC, SN50 and parthenolide suggested the involvement of NF-kB in the Ad.CFTR-dependent transcription of ICAM-1. As transcriptionally-defective Ads have been shown to induce cellular immune or inflammatory responses, we investigated whether adenoviral gene expression is required to upregulate ICAM-1 mRNA levels by inactivating Ad.CFTR by heat. [20] [21] [22] [23] As shown in Figure 3a , Ad.CFTR treated at 37°C or 56°C for 20 min before infection induced upregulation of ICAM-1 mRNA, whereas no increase was found at 99°C. To investigate the effect of temperature on viral genes expression, we analyzed the trascription of different regions of Ad.CFTR. Infection of A549 cells with the E1-E3-deleted adenoviral vector Ad.CFTR results in expression of proteins encoded by early and late viral genes like DNA binding protein (DBP) and fiber, in addition to CFTR. 24 We therefore checked the transcription of E2a (DBP), L5 (fiber), the expression cassette (CFTR) and the A549 endogenous ICAM-1 using a very sensitive assay, such as nested RT-PCR. Since expression of the E4 genes is considered relevant to the inflammatory and cytotoxic response, different second and third generation E4-deleted vectors have been produced. 25 Therefore we checked the transcription of E4 region, within a common E4-ORFs sequence. 26, 27 All these genes are transcribed when Ad.CFTR was preincubated at 37°C, as shown in Figure 3b , consistent with previously reported data. 24 On the contrary no expression of viral genes was observed at 56 and 99°C. Therefore ICAM-1 mRNA upregulation observed with Ad.CFTR preincubated at 56°C indicates that viral gene expression is not likely to be required.
The results obtained with the inhibitors of NF-kB have been extended by examining the different steps of NFkB activation, starting from the process of NF-kB nuclear translocation. This has been performed by immunofluorescence, using an antibody directed against the p65 subunit of NF-kB. An exclusively cytoplasmic signal was detected in the perinuclear region of uninfected A549 cells (Figure 4a ), whereas a strong nuclear signal was observed after infection with Ad.CFTR ( Figure 4b ). No nuclear signal was observed when cells exposed to Ad.CFTR were assayed with a rabbit preimmune serum (not shown). This indicates that Ad.CFTR induces nuclear translocation of NF-kB.
The ability of translocated NF-kB to bind to the proximal kB site of the ICAM-1 promoter was assessed by electrophoretic mobility shift assay (EMSA). Several potential NF-kB binding sites have been described in the ICAM-1 5′ flanking region being the −228/−218 kB site known to bind NF-kB proteins. 4, 28, 29 Nuclear extracts were incubated with the 32 P-labeled oligonucleotide including the wild-type −228/−218 kB site of ICAM-1 promoter and subjected to gel-electrophoresis. DNA binding activity was undetectable in nuclei from uninfected cells (Figure 5a , lane 2). After incubation of nuclear extracts obtained from cells infected with Ad.CFTR we observed a band with altered mobility (Figure 5a, lane 3) . No bind- ing was observed when nuclear extracts from infected cells were incubated with a labeled probe bearing substitutions in the kB site (Figure 5a, lane 4) confirming the specificity of the oligonucleotide sequence able to generate the retarded complex. The altered mobility of the complex was abolished when infection was performed in the presence of the inhibitors of NF-kB activation parthenolide (Figure 5a Taken together these results demonstrate that Ad.CFTR-activated NF-kB is able to bind to the −228/−218 kB site described in the ICAM-1 promoter.
Figure 4 Ad.CFTR induces nuclear translocation of NF-kB. A549 cells were seeded on eight-well chamber slides (Nunc, Naperville, IL, USA) in complete Dulbecco's modified Eagle's medium (DMEM) (ICN Biomedicals, Costa Mesa, CA, USA) supplemented with 10% fetal bovine serum (FBS; Hyclone, Logan, UT, USA). 24 h after seeding the medium was removed and replaced with medium supplemented with 2% FBS containing Ad.CFTR at 50 MOI (B) or medium alone (A). The virus was left in place for 24 h, then cells were washed three times with phosphate buffered saline solution (PBS) pH 7.4 and fixed with 4% paraformaldehyde (w/v) in PBS for 20 min at room temperature. After washing three times with PBS, cells were permeabilized for 6 min with methanol at −20°C and then air dried for 1 h. Slides were incubated with 5% bovine serum albumin (BSA) in PBS for
In order to determine whether the binding of NF-kB to Figure 2 the ICAM-1 promoter following Ad.CFTR infection might result in transcriptional activation, we designed vectors including the −228/−218 kB wild-type site driving the expression of the CAT reporter gene, as described in Figure 6a . A mutated version has been also set up to check for binding specificity. The ICAM-1 promoter activity in cells transfected with the reporter vector containing the wild-type NF-kB site (p224wt) increased 13-fold after adenoviral infection with respect to vehicletreated transfectants (Figure 6b ). This activation was dependent on the ICAM-1 promoter, as Ad.CFTR infection did not change CAT activity in cells transfected with the promoter-less vector pcat. The signal was dependent on the NF-kB binding to ICAM-1 promoter as Ad.CFTR did not induce CAT activity in respect to vehicle in cells transfected with p224m. Also, no basal activity can be attributed to the ICAM-1 promoter region included in our reporter vector, as transfectants receiving the wildtype reporter vector or the promoter-less vector had very similar levels of CAT activity in the absence of Ad.CFTR. These data demonstrate that binding of Ad.CFTRactivated NF-kB to its consensus sequence in the proxi- mal ICAM-1 5′ flanking region is capable of inducing transcriptional activity. Since different inhibitors of NFkB activation abolish the Ad.CFTR-dependent induction of ICAM-1 mRNA as shown in Figure 2b , these were tested on the Ad.CFTR-induced transactivation of CAT in cells transfected with the p224wt construct. Cells transfected with the wild-type reporter construct were preincubated with the NF-kB inhibitors already described and infected with Ad.CFTR. Ad.CFTR-dependent CAT activity was completely suppressed by SN50, NAC, PDTC and parthenolide, as shown in Figure 6c . Reporter activity induced by Ad.CFTR was unaffected by SN50M, demonstrating the specificity of SN50 inhibition. Therefore, the results obtained with the inhibitors and the mutated reporter vector indicate that NF-kB is involved in adenovirus-induced reporter activity, making it unlikely that transcription factors other than NF-kB might be responsible for the CAT activity observed.
NF-kB consensus sequence is underlined in NFW and substitutions are shown by lower case in NFM. Protein-DNA complexes were resolved on a 5% non-denaturing polyacrylamide gel in 0.25 × TBE at room temperature for 3 h at 120 V. Gels were dried and autoradiographed. (a) Effect of parthenolide, NAC and PDTC on DNA binding to Ad.CFTR-activated NF-kB. Free probe NFW (lane 1). EMSA analyzes DNA binding activity to the probe NFW from: uninfected A549 cells (lane 2); cells infected for 24 h with Ad.CFTR at MOI 10 (lane 3), cells infected in the presence of parthenolide, NAC and PDTC (lanes 5, 6 and 7, respectively). Cells were treated as described in Figure 2. Parthenolide was dissolved in chloroform, which did not affect nuclear DNA binding activity (not shown). Nuclear extracts from infected cells were incubated with the labeled NFM probe in order to establish the specificity of the complex (lane 4). The results are representative of at least three independent experiments. (b) Effect of the synthetic peptide SN50 on DNA binding to Ad.CFTR-activated NFkB. Binding activity to the probe NFW from: uninfected A549 cells (lane 1); cells infected for 24 h with Ad.CFTR (MOI 10) (lane 2) in the presence of SN50M (lane 3) and SN50 (lane 4) incubated as described in
The present study demonstrates that: (1) exposure of the Ad-derived vector Ad.CFTR to A549 cells causes nuclear translocation of NF-kB; (2) NF-kB binds to the proximal NF-kB consensus sequence of the ICAM-1 promoter; (3) binding of NF-kB to the proximal binding site of ICAM-1 promoter induces transcriptional activity; (4) inhibition of NF-kB activation suppresses Ad.CFTRinduced ICAM-1 mRNA transcription. Therefore, we provide evidence that ICAM-1 mRNA upregulation induced by first generation Ad-derived vectors previously reported in A549 cells is mediated by NF-kB activation. 1, 2 As each of the four inhibitors suppresses the induction of ICAM-1 mRNA by Ad.CFTR, NF-kB seems to be the key converging factor for transcriptional activation, even though this approach can not completely exclude the cooperation of other factors.
Besides the activation of ICAM-1 observed, NF-kB is considered a master regulator of the inflammatory and immune responses, capable of providing the mediators required in the network of events leading to the host response. 11 Among a large series, it should be recalled that NF-kB can induce mediators like IL-1␤, tumor necrosis factor alpha, IL-2, IL-6, IL-8, IP-10, interferon gamma, MIP-1␣, MIP-2␣, MCP-1, which have been found elevated when first generation Ad-derived vectors were exposed to respiratory cells in vitro and in vivo. [30] [31] [32] [33] [34] Therefore the results presented here stress the importance of investigating the possible involvement of NF-kB in the induction of these pro-inflammatory cytokines upon exposure to Ad-derived vectors.
The understanding of the mechanism(s) by which Ad.CFTR activates NF-kB is relevant to novel gene therapy strategies. The process of viral replication has been associated with the production of NF-kB-dependent IL-8 by respiratory syncytial virus in A549 cells. 35 Also, products encoded by the E1a and E3 early genes of Ad serotype 5 have been associated with NF-kB activation. 36, 37 In our experimental model neither viral replication nor gene transcription seem involved, as we observed that ICAM-1 mRNA upregulation is induced by a E1-E3-deleted Ad vector even after inhibition of E2a and E4 transcription by heat inactivation. Interestingly, capsid-dependent regulation of proinflammatory mediators has already been reported. 22, 23 This opens the possibility that the early events of Ad binding, internalization and dismantling in which structural viral proteins interact with different receptors before viral replication could be important mechanisms eliciting the inflammatory response to Ad-derived vectors.
Upregulation of ICAM-1 and release of pro-inflammatory cytokines have been consistently observed in A549 cells, which derive from alveolar type II pneumocytes, while bronchial cell models either as primary cultures or immortalized lines were not responsive to Ad-derived vectors in vitro. 1, 2, 31, 38, 39 Induction of inflammation has been characterized in animal models in which the vector may reach at least in part the alveolar space, as shown by in situ hybridization of the CFTR mRNA in the alveolar epithelium. 32 In human clinical trials the most serious pulmonary inflammatory response was observed in an individual where a large volume was delivered to the lungs by bronchoscope, whereas the response to the same amount of vector administered in a smaller volume was less significant. 30, 40 These findings open the question on whether the inflammatory response described upon exposure to Ad-derived vectors is elicited only when they reach the alveolar space, which will be unlikely in humans after aerosol administration. With regards to localization in the lung, studies in nonhuman primates showed that mononuclear cell infiltrates related to innate and specific immune response have been found both in the interstitial alveolar and in the peribronchial spaces. We previously detected ICAM-1 mRNA upregulation not only in lobe portions, but also in main bronchi positive for cell infiltrates. 2, 32, 41 Therefore the inflammatory and immune responses do not appear to be confined exclusively to the alveoli. This important issue will require further investigation.
Dexamethasone has been shown to increase the efficiency of Ad-mediated gene transfer in murine lungs in vivo, suggesting that non-specific inflammation is one of the crucial steps limiting the use of Ad-derived vectors in CFTR gene transfer into the airway tract. 34 In this respect, some of the inhibitors presented in this study have been already utilized in animal models by systemic infusion in order to limit different pathologies derived from NF-kB activation in vivo. For instance, PDTC has been shown to abrogate ICAM-1 expression in the treatment of septic shock in rats and to attenuate lung reperfusion injury in a porcine lung transplantation model. NAC has also been demonstrated to suppress neutrophilic lung inflammation in endotoxin treated rats. [42] [43] [44] As these molecules completely inhibited the activation of NF-kB by Ad.CFTR, the results presented here can prelude to pharmacological studies aimed at limiting the host response following vector administration. Moreover, further insights on the mechanism(s) of activation of NFkB by adenoviral vectors will aid in the development of gene transfer vectors which minimize the adverse host response.
